Abstract: The entire process of developing a drug from preclinical research to marketing can take approximately 12 to 18 years and often costs well over $1 billion. Global Top Pharmaceutical ... billion in 2023 and is…
study is to discuss the latest information released into the medical literature regarding novel drug therapy of depression in Parkinson’s disease. Methods: A wide search of the medical literature
raised regarding oral anticoagulants, HIV antiretroviral therapy, cancer treatments,central nervous system medications, and drug management in the elderly and in chronic kidney disease patients. Proton pumpinhibitors…
Introduction Drug–polymer interactions are a fundamental aspect of pharmaceutical science, particularly in the design and development of advanced drug delivery systems. Polymers are widely used as carriers, coatings…
Introduction Transdermal drug delivery refers to the administration of therapeutic agents across the skin for systemic effect. It offers important advantages over oral and injectable routes, including avoidance of first…
article was selected when we searched for DD/NP/documented pathogenesis/respond to drug therapy. Conclusions: Based on the systematic review of the medical literature we also released novel hypotheses
Drug-toxicology is a critical field in understanding and mitigating the risks associated with drug exposure. By evaluating the adverse effects of pharmaceuticals on biological systems, drug-toxicology plays ... pivotal…
science and activities related to the detection, assessment, understanding, and prevention of adverse drug reactions (ADRs) and drug-related problems, is an essential component of clinical pharmacology. By…
stands as a very uncommon neurological condition marked by refractory epilepsy to Antiepileptic Drugs (AED) typically emerging during childhood, marked by a progressive unilateral hemispheric degeneration of the brain…
Pancreatic tumors pose a unique challenge for drug delivery due to the presence of hypoxic regions. Vinblastine-N-Oxide (CPD100) is a hypoxia-activated prodrug (HAP) that selectively transforms into